These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 925382)

  • 21. Safety and immunogenicity in man of a cell culture derived trivalent live attenuated seasonal influenza vaccine: a Phase I dose escalating study in healthy volunteers.
    Heldens J; Hulskotte E; Voeten T; Breedveld B; Verweij P; van Duijnhoven W; Rudenko L; van Damme P; van den Bosch H
    Vaccine; 2014 Sep; 32(39):5118-24. PubMed ID: 24858566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interpretation of responses and protective levels of antibody against attenuated influenza A viruses using single radial haemolysis.
    Al-Khayatt R; Jennings R; Potter CW
    J Hyg (Lond); 1984 Oct; 93(2):301-12. PubMed ID: 6389697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intranasal M2SR (M2-Deficient Single Replication) H3N2 Influenza Vaccine Provides Enhanced Mucosal and Serum Antibodies in Adults.
    Eiden J; Fierro C; Schwartz H; Adams M; Ellis KJ; Aitchison R; Herber R; Hatta Y; Marshall D; Moser MJ; Belshe R; Greenberg H; Coelingh K; Kawaoka Y; Neumann G; Bilsel P
    J Infect Dis; 2022 Dec; 227(1):103-112. PubMed ID: 36350017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Responses of elderly and chronically ill subjects to bivalent influenza A/New Jersey/8/76 (Hsw1N1)-A/Victoria/3/75 (H3N2) vaccines.
    Douglas RG; Bentley DW; Brandriss MW
    J Infect Dis; 1977 Dec; 136 Suppl():S526-32. PubMed ID: 342625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small-scale trial of live-attenuated influenza vaccine (A/Hong Kong/68).
    West R; Stewart JA; White FM; McDonald JC; Boudreault A; Pavilanis V
    Can J Microbiol; 1977 Mar; 23(3):253-7. PubMed ID: 322827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the protective efficacies of the live vaccine RIT 4025 and an inactivated vaccine against a natural heterologous A/Victoria/3/75 infection.
    Delem A; Van Rensburg W; Flaskett I
    J Hyg (Lond); 1979 Oct; 83(2):221-9. PubMed ID: 385764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults.
    Block SL; Yi T; Sheldon E; Dubovsky F; Falloon J
    Vaccine; 2011 Nov; 29(50):9391-7. PubMed ID: 21983154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resistance of adults to challenge with influenza A wild-type virus after receiving live or inactivated virus vaccine.
    Clements ML; Betts RF; Tierney EL; Murphy BR
    J Clin Microbiol; 1986 Jan; 23(1):73-6. PubMed ID: 3700611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants.
    Wong TM; Allen JD; Bebin-Blackwell AG; Carter DM; Alefantis T; DiNapoli J; Kleanthous H; Ross TM
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children.
    Belshe RB; Mendelman PM; Treanor J; King J; Gruber WC; Piedra P; Bernstein DI; Hayden FG; Kotloff K; Zangwill K; Iacuzio D; Wolff M
    N Engl J Med; 1998 May; 338(20):1405-12. PubMed ID: 9580647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical control, study of viral shedding and evaluation of circulating and local antibody response after administration of live and attenuated "Alice" strain influenza vaccine].
    Bergamini F; Profeta ML; Ferroni P; Zanetti AR
    Boll Ist Sieroter Milan; 1976 Mar; 55(71):1-12. PubMed ID: 1021151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective efficacy of RIT 4025, a live attenuated influenza vaccine strain, and evaluation of heterotypic immunity to influenza A viruses in ferrets.
    Delem A
    J Hyg (Lond); 1977 Oct; 79(2):203-8. PubMed ID: 269196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses: a single-centre, double-blind, randomised, controlled phase 2b/3 trial.
    Hung IF; Zhang AJ; To KK; Chan JF; Li P; Wong TL; Zhang R; Chan TC; Chan BC; Wai HH; Chan LW; Fong HP; Hui RK; Kong KL; Leung AC; Ngan AH; Tsang LW; Yeung AP; Yiu GC; Yung W; Lau JY; Chen H; Chan KH; Yuen KY
    Lancet Infect Dis; 2016 Feb; 16(2):209-18. PubMed ID: 26559482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine.
    Belshe RB; Gruber WC; Mendelman PM; Mehta HB; Mahmood K; Reisinger K; Treanor J; Zangwill K; Hayden FG; Bernstein DI; Kotloff K; King J; Piedra PA; Block SL; Yan L; Wolff M
    J Infect Dis; 2000 Mar; 181(3):1133-7. PubMed ID: 10720541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6-59 months of age.
    Mallory RM; Yi T; Ambrose CS
    Vaccine; 2011 Jun; 29(26):4322-7. PubMed ID: 21513761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunity to attenuated influenza virus WRL 105 infection induced by heterologous, inactivated influenza A virus vaccines.
    Potter CW; Jennings R; Nicholson K; Tyrrell DA; Dickinson KG
    J Hyg (Lond); 1977 Dec; 79(3):321-32. PubMed ID: 270523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. M2-Deficient Single-Replication Influenza Vaccine-Induced Immune Responses Associated With Protection Against Human Challenge With Highly Drifted H3N2 Influenza Strain.
    Eiden J; Volckaert B; Rudenko O; Aitchison R; Herber R; Belshe R; Greenberg H; Coelingh K; Marshall D; Kawaoka Y; Neumann G; Bilsel P
    J Infect Dis; 2022 Aug; 226(1):83-90. PubMed ID: 34323977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Failure of attenuated temperature-sensitive influenza A (H3N2) virus to induce heterologous interference in humans to parainfluenza type 1 virus.
    Murphy BR; Richman DD; Chalhub EG; Uhlendorf CP; Baron S; Chanock RM
    Infect Immun; 1975 Jul; 12(1):62-8. PubMed ID: 166929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of heterosubtypic immunity on infection with attenuated influenza A virus vaccines in young children.
    Steinhoff MC; Fries LF; Karron RA; Clements ML; Murphy BR
    J Clin Microbiol; 1993 Apr; 31(4):836-8. PubMed ID: 8463393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective efficacy in mice of monovalent and trivalent live attenuated influenza vaccines in the background of cold-adapted A/X-31 and B/Lee/40 donor strains.
    Jang YH; Lee EY; Byun YH; Jung EJ; Lee YJ; Lee YH; Lee KH; Lee J; Seong BL
    Vaccine; 2014 Jan; 32(5):535-43. PubMed ID: 24342248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.